26/04/28
2026/04/28
管理员
New progress has been made in skin wound repair and regenerative medicine, particularly through the regulation of macrophage polarization.
Learn More26/04/28
2026/04/28
管理员
New progress has been made in identifying novel targets for cancer immunotherapy through single-cell screening.
Learn More26/04/20
2026/04/20
管理员
New progress has been made in the field of immunotherapy for PD-L1–resistant tumors.
Learn More26/04/20
2026/04/20
管理员
This study provides new insights into antibody-mediated chemical engineering of γδ T cells for enhancing tumor-targeting capability and improving antitumor immune responses.
Learn More26/01/05
2026/01/05
管理员
Recently, Guangzhou Biolight Biotechnology Co., Ltd. (hereinafter referred to as “BLT”) announced that its core product, the AniView series of live imaging systems, has secured a series of significant orders in overseas markets.
Learn More25/11/16
2025/11/16
管理员
On 2025 November 7, the UCLA Crump Institute for Molecular Imaging (CIMI-UCLA) and Guangzhou Biolight Technology Co., Ltd. (BLT) jointly announced the establishment of the CIMI-UCLA & BLT In Vivo Imaging Center at the University of California, Los Angeles.
Learn More25/10/21
2025/10/21
管理员
New York University Abu Dhabi (NYUAD) recently hosted a seminar and technical workshop featuring Guangzhou Biolight Biotechnology Co., Ltd. (hereinafter referred to as BLT) , invited to present its cutting-edge AniView Phoenix100 Full-Spectrum In Vivo Imaging System.
Learn More25/05/27
2025/05/27
Recently, Professor Li Xinping's team from the College of Agricultural Equipment Engineering at Henan University of Science and Technology has made new progress in the study of the mechanism of corn shelling damage through applying Skyview.
Learn More